Ledger.Open graph →
SEC Form D · Amendment · filed April 17, 2018

CARMA Therapeutics Inc

Offering
$3.9M
Sold
$3.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Margarita Chavez · Philadelphia, PADirectorSteven Kelly · Dublin, IrelandExec · DirectorBruce Peacock · Philadelphia, PADirectorMichael Poisel · Wilmington, DEDirectorTrey Hilberg · San Francisco, CAExec · DirectorNicholas A. Nash · NA, U0DirectorStacey Y. Goodman · Newark, NJDirectorDavid A. Kloske · Huntsville, ALDirectorDavid T. Moore · Huntsville, ALExec · DirectorDanny J. Windham · Huntsville, ALDirectorMichael Poisel · Wilmington, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗